November 20, 2009 - Importance of Real-Time CPR Feedback Presented at AHA Scientific Sessions

INVESTOR CONTACT:

A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655

MEDIA CONTACT:

Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
degan@zoll.com

IMPORTANCE OF REAL-TIME CPR FEEDBACK  PRESENTED AT AHA SCIENTIFIC SESSIONS 2009

ZOLL’s PocketCPR for iPhone Training App Debuts to Over 17,000 Downloads During AHA

November 20, 2009CHELMSFORD, MASS.–ZOLL Medical Corporation (Nasdaq GS: ZOLL) announced today that the importance of real-time feedback to improve the quality of CPR was presented  in two separate poster presentations at the American Heart Association 2009 Scientific Sessions in Orlando, Florida this week.  ZOLL’s exclusive real-time feedback technology, Real CPR Help®, is now available in virtually all of the Company’s defibrillators, AEDs and its PocketCPR® device to help improve CPR performance and outcomes in victims of sudden cardiac arrest (SCA).

Charles N. Pozner, M.D., Director of STRATUS Center for Medical Simulation, Brigham & Women’s Hospital, Boston, and David Barash, M.D. Concord Healthcare Strategies, Concord, Mass., et al., presented “Early Marker of Rescuer Fatigue,” citing the key conclusion that the CPR feedback device (PocketCPR) provided objective and reliable measurement of chest compression depth and could be an accurate marker of rescuer fatigue. The handheld CPR feedback device significantly improved the quality of chest compressions provided by experienced hospital providers.

The second poster presentation by Drs. Pozner and Barash et al., entitled “Do We Need to Switch Rescuers Every Two Minutes” concluded that with real-time CPR feedback, hospital providers could perform chest compressions for four minutes without degradation in the depth of compressions, thus allowing for fewer interruptions to switch rescuers.   

“We are greatly encouraged that an increasing number of studies are seeing the value of ZOLL’s technology that provides rescuers with prompts and measurements that improve CPR quality,” said Richard A. Packer, President and CEO of ZOLL.   “Our key focus has been to help improve outcomes from sudden cardiac arrest, and supporting research from clinicians is an important indication of the strides we are making.”    

PocketCPR for iPhone App Training Device Well-Received

ZOLL’s PocketCPR® for iPhone app, which debuted at the ZOLL booth during AHA and was also available from the Apple iTunes App Store, registered more than 17,000 downloads during its first week of availability.  People from 57 countries downloaded the CPR Training app to their iPhone or iPod Touch during the dates of the conference. 

The app provides an easy-to-use CPR training program and a tool to practice life saving skills.  PocketCPR uses Real CPR Help technology identical to the featured in ZOLL defibrillator and AEDS.  The app is available now at an introductory price of only $2.99 for a limited time following the AHA conference.

To purchase or view the application, any user of an iPhone or iPod Touch needs to enter the App Store from their device, or via iTunes on their computer, using PocketCPR as the search term.   When the PocketCPR for iPhone icons appears, click the Buy App icon to purchase the application.

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company for the past three years, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on August 7, 2009. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, PocketCPR, and Real CPR Help, P are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.